Authorisation AR 30-06-04
In accordance with article 24 §1 of the law of 7th May 2004 (PDF, 165.52 Kb) concerning experiments on humans, an authorisation is required for manufacturing and importing experimental medicines. Such an authorisation is also required if the experimental medicine is intended for exportation. The distribution of experimental medicines requires the authorisation referred to in article 12 part 3 of the law of 25th March 1964 (PDF, 802.97 Kb) concerning medicines.
The Royal Decree dated 30th June 2004 (PDF, 91.81 Kb), which defines the measures for implementing the law of 7th May 2004 about experiments on humans for clinical trials of medicines for human use, states the details of the cases where authorisation is required, the conditions and details that must be met to obtain it, and the requirements that an authorisation holder must meet. Article 16 refers to manufacture of medicines intended for clinical trials, to importation for manufacture or importation of medicines for clinical trials that are received packaged from a country outside the EU / EES (European Economic Space)
The Royal Decree of 14th December 2006 (PDF, 2.02 MB) about medicines for human and veterinary use applies to the importation of medicines packaged in an EU / EES country, to stocking and distributing medicines for clinical trials, and also for exportation of packaged medicines.
The authorisation request – Royal Decree 30/06/2004 (DOC, 723.5 Kb) (a new request, a request for a change to the authorisation or a request to change the approved installations), plus appendix 1 if necessary « Field of application of the authorisation » (DOC, 86.5 Kb) , must be submitted with all the required documents to :
Federal Agency for Medicines and Health Products (FAMHP) Eurostation II, 8th floor, Place Victor Horta, 40 box 40, 1060 Brussels.
The amount of the fee to be paid when applying for a new authorization is 1327.66 €.
For the modification of an authorization or the modification of an approved installation the amount is 53.53 €. The fee must be paid into the FAMHP account (679-0021942-20).